Hypoxia-inducible factor 1 (HIF-1) is the central mediator of cellular responses to low
oxygen and has recently become an important therapeutic target for solid
tumor therapy. Inhibition of HIF-1 is expected to result in the attenuation of
hypoxia-inducible genes, which are vital to many aspects of
tumor biology, including adaptative responses for survival under anaerobic conditions. To identify small molecules inhibiting the HIF-1 pathway, we did a
biological screen on a 10,000-membered
natural product-like combinatorial library. The compounds of the library, which share a 2,2-dimethylbenzopyran structural motif, were tested for their ability to inhibit the hypoxic activation of an
alkaline phosphatase reporter gene under the control of
hypoxia-responsive elements in human
glioma cells. This effort led to the discovery of
103D5R, a novel small-molecule inhibitor of HIF-1alpha.
103D5R markedly decreased HIF-1alpha
protein levels induced by
hypoxia or cobaltous
ions in a dose- and time-dependent manner, whereas minimally affecting global cellular
protein expression levels, including that of control
proteins such as HIF-1beta,
IkappaBalpha, and
beta-actin. The inhibitory activity of
103D5R against HIF-1alpha was clearly shown under normoxia and
hypoxia in cells derived from different
cancer types, including
glioma, prostate, and breast
cancers. This inhibition prevented the activation of HIF-1 target genes under
hypoxia such as
vascular endothelial growth factor (
VEGF) and
glucose transporter-1 (Glut-1). Investigations into the molecular mechanism showed that
103D5R strongly reduced HIF-1alpha
protein synthesis, whereas HIF-1alpha
mRNA levels and HIF-1alpha degradation were not affected.
103D5R inhibited the phosphorylation of Akt, Erk1/2, and stress-activated
protein kinase/c-jun-NH(2)-
kinase, without changing the total levels of these
proteins. Further studies on the mechanism of action of
103D5R will likely provide new insights into its validity/applicability for the pharmacologic targeting of HIF-1alpha for therapeutic purposes.